FindTrial
Sign In

Questionnaire based study of drugs taken by healthcare workers to prevent COVID 19

ICMR â?? RUMC COVID 19 Study for the Assessment of Prophylaxis For Health Care Workers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025183
Enrollment
5000
Registered
2020-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Indian Council of Medical Research ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consenting Health Care Workers working in ICMR RUMC and collaborating hospitals caring for Covid-19 patients

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
In HCW working in hospitals caring for COVID 19 patients, we will understand the rates of and types of drugs used, doses taken for prophylaxis, concomitant illness, concomitant medications, adverse reactions if any and the COVID-19 status at the end of the prophylaxis period. We will also understand the reasons why HCW did not take prophylaxis or discontinued.Timepoint: To be studied at the end of 12 weeks of prophylaxis or later if the recommendations change—

Secondary

MeasureTime frame
We will estimate /compare the Covid-19 status (SARS Co v2 positivity, symptoms) in those taking prophylactic treatment and those not taking prophylactic treatment.Timepoint: To be studied at the end of 12 weeks of prophylaxis or later if the recommendations change—

Countries

India

Contacts

Public ContactDr Denis Xavier

St. Johns Medical College

denis.xavier@stjohns.in9886126801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026